Figure S6 from in Vivo Epigenetic CRISPR Screen Identifies Asf1a As an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
Fei Li,Qingyuan Huang,Troy A. Luster,Hai Hu,Hua Zhang,Wai-Lung Ng,Alireza Khodadadi-Jamayran,Wei Wang,Ting Chen,Jiehui Deng,Michela Ranieri,Zhaoyuan Fang,Val Pyon,Catríona M. Dowling,Ece Bagdatlioglu,Christina Almonte,Kristen Labbe,Heather Silver,Alexandra R. Rabin,Kandarp Jani,Aristotelis Tsirigos,Thales Papagiannakopoulos,Peter S. Hammerman,Vamsidhar Velcheti,Gordon J. Freeman,Jun Qi,George Miller,Kwok-Kin Wong openalex（2023）
摘要
Asf1a KO synergizes with anti-PD-1 to inhibit tumor progression in multiple models
更多查看译文
AI 理解论文
溯源树
样例
